---
title: "Kelun Pharmaceutical Gets Chinese Drug Registration for Antibiotic"
date: "2025-02-10 13:23:40"
summary: "Sichuan Kelun Pharmaceutical obtained registration approval from China's drug administrator for its Imipenem-cilastatin sodium/sodium chloride injection. Combined with cilastatin sodium, carbapenem antibiotic imipenem can avoid inactivation by kidney metabolism and improve kidney safety, according to a Saturday filing with the Shenzhen bourse. Shares of the pharmaceutical company rose 1% in..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Sichuan Kelun Pharmaceutical obtained registration approval from China's drug administrator for its Imipenem-cilastatin sodium/sodium chloride injection.

Combined with cilastatin sodium, carbapenem antibiotic imipenem can avoid inactivation by kidney metabolism and improve kidney safety, according to a Saturday filing with the Shenzhen bourse.

Shares of the pharmaceutical company rose 1% in recent trade.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465443:0/)
